Ethics of PGD: thoughts on the consequences of typing HLA in embryos.
As with so many fields of study associated with assisted human reproduction, many ethical issues are raised by the practice of preimplantation diagnosis of inherited disease (PGD). Some are part and parcel of assisted conception, e.g.the rights of human embryos in vitro and of embryologists to establish them, carry out research and discard them. Others unique to clinical PGD were discussed at an earlier meeting on PGD (Edwards et al., 2003). Recent developments in PGD are discussed briefly in this Commentary, especially the ethics of designer babies.
Edwards
R G
RG
D001675:Bioethics; D004622:Embryo, Mammalian / Q000276:immunology*; D005199:Fanconi Anemia / Q000235:genetics / Q000628:therapy; D005260:Female; D005306:Fertilization; D005307:Fertilization in Vitro / Q000941:ethics; D030342:Genetic Diseases, Inborn / Q000628:therapy; D005820:Genetic Testing / Q000941:ethics; D006680:HLA Antigens / Q000276:immunology; D006650:Histocompatibility Testing / Q000941:ethics* / Q000379:methods*; D006801:Humans; D008297:Male; D011247:Pregnancy; D019836:Preimplantation Diagnosis / Q000941:ethics*; D033581:Stem Cell Transplantation
D006680:HLA Antigens